Neuralink, the brain chip startup founded by Elon Musk, has received approval to launch its first clinical study in Canada. The study aims to evaluate the safety and initial functionality of a device designed to enable paralyzed individuals to control digital devices through thought alone.
The University Health Network in Toronto has been selected to perform the complex neurosurgical procedure, as confirmed in a separate statement. Health Canada has not yet responded to requests for comments.
In the United States, Neuralink has already implanted the device in two patients, with reports indicating successful functionality in the second patient, who has used it to play video games and learn 3D design.
Founded in 2016, Neuralink is also developing a brain chip interface that could ultimately assist patients with disabilities in regaining movement and communication abilities, as well as restoring vision. In September, the startup received a 'breakthrough device' designation from the U.S. Food and Drug Administration for its experimental vision restoration implant.